Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This study is to demonstrate the safety, tolerability, pharmakokinetic and pharmacodynamic
effect of BAY63-2521 in patients with pulmonary hypertension and stable treatment of
sildenafil 20 mg.